the government of canada is committed to taking actions to protect endangered whale populations. through funding provided in budget 2018 and the government of canada’s oceans protection plan, fisheries and oceans canada (dfo) and the natural sciences and engineering research council of canada (nserc) are partnering to support research that will enhance scientific research on marine mammals in canada with a focus on southern resident killer whales, north atlantic right whales, and the saint lawrence estuary population of beluga whales. in particular, research on whale health (such as effects of contaminants) and condition (in the context of threat identification), effectiveness of threat mitigations, and whale assessment methodologies (including innovative survey technologies) are directly relevant to dfo’s programs and priorities.

the anticipated budget for this initiative is $3 million, and individual proposals should not exceed $1 million over their duration. part of the funding will be administered directly by dfo and must respect the program requirements of the dfo ocean and freshwater science contribution program. under these requirements, dfo’s contribution must not exceed 50% of eligible costs of any project for private sector recipients and 75% of eligible costs of any project for other recipients. nserc’s funds will be administered according to its use of grant funds guidelines, outlined in the tri-agency financial administration guide. the maximum level (stacking limit) of total government assistance (federal, provincial, and municipal assistance for the same eligible expenditures) must not exceed 100% of eligible expenditures.

please note that only one application per university will be accepted under this call.

the early career faculty (ecf) grants are a unique opportunity for early-career faculty investigators to contribute to and participate in meopar’s broad interdisciplinary, multi-institutional research effort, thereby growing and extending their network of collaborators and interactions with stakeholders. meopar recognized the need for support of early career investigators (who received their first faculty appointment in the last five years) to maximize their considerable potential.

this call is specifically targeted at individuals early in their academic research careers.

the ecf program provides individual research grants; therefore, the only investigator to receive funds on the project will be the principal investigator (pi). only one application per pi will be considered. there are between 12-15 grants available under this program. the maximum funding level available for each grant is $100,000. meopar will support research projects that are two years in length, beginning in april 2019. annual funding will be split in half, with the first half administered in april and the second in october.

the specific objectives of this funding opportunity are:

• to provide recognition and funding to academic researchers;
• to provide a reliable supply of highly skilled and qualified researchers.

the foundation grant program is designed to contribute to a sustainable foundation of established health research leaders, by providing long-term support for the pursuit of innovative and high-impact research programs.

the foundation grant program is expected to:

• support a broad base of health research leaders across all health-related disciplines with a demonstrable track record of excellence and impact in their field of study;
• develop and maintain canadian capacity in health research and other related fields;
• provide research leaders with the flexibility to pursue novel and innovative lines of inquiry;
• contribute to the creation and application of health-related knowledge through a wide range of research and/or knowledge translation activities, including relevant collaborations.

the project grant program is expected to:

• support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization;
• promote relevant collaborations across disciplines, professions, and sectors;
• contribute to the creation and use of health-related knowledge.

the fy18 defense appropriations act provides $80 million (m) to the department of defense peer reviewed cancer research program (prcrp) to support innovative, high-impact cancer research.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, (dha) j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy18 prcrp program announcements and general application instructions for the following award mechanisms are posted on grants.gov. 

congressionally directed topic areas:  to be considered for funding, applications for the fy18 prcrp must address at least one of the topic areas as directed by congress.  research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, or ovarian cancer will not be accepted.

the fy18 prcrp topic areas are:

*the definition of adolescents and young adults is derived from the national cancer institute (https://www.cancer.gov/types/aya) and can be considered to be people between the ages of 15-39 years.  cancers studied under this topic area should be within the scope of the congressional language and the intent of the program announcement(s)

^†as derived from the national cancer institute dictionary of cancer terms (http://www.cancer.gov/publications/dictionaries/cancer-terms).  immunotherapy is a type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer.  cancers studied under this topic area should be within the scope of the congressional language and the intent of the program announcement(s).

the fy18 prcrp military relevance focus areas are listed below:

to address the cancer health needs of both deployed and non-deployed personnel, their dependents, retirees, and veterans, the fy18 prcrp seeks to support studies that are responsive to at least one of military relevance focus areas listed below:

• militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, environmental carcinogens, and stress)
• gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may impact mission readiness and the health and well-being of military members, veterans, and their beneficiaries and the general public

http://cdmrp.army.mil/funding/prcrp

horizon award – letter of intent due august 28, 2018

principal investigator (pi): predoctoral candidate within 2 years of completion of required coursework/laboratory rotations, successfully passed qualifying examinations, and is working in his/her mentor’s laboratory application submission deadline.

or

postdoctoral fellow within 3 years of completion of terminal degree and is working in his/her mentor’s laboratory at application submission deadline.

mentor: investigators at or above the level of assistant professor (or equivalent); must have a proven publication and funding record in cancer research.

pi and mentor must be at the same organization.

·         letter of intent is required.  an invitation to submit a full application is not required.

·         supports junior-level scientists in conducting impactful research with the mentorship of an experiences cancer research (i.e., mentor).

·         must address at least one of the fy18 prcrp topic areas.

·         must address at least one of the fy18 prcrp military relevance focus areas.

·         preliminary data are not required.

·         clinical trials are not allowed.

·       maximum funding for the entire period of performance is $150,000 for direct costs (plus indirect costs)

·       maximum period of performance is 2 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org/.  for more information about the prcrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507

help@ebrap.org

the mitacs globalink research award provides $6,000 for senior undergraduate and graduate 世界杯2022赛程表淘汰赛 in canada to conduct 12–24-week research projects at universities overseas.

in the warm and gentle days of summer, planning for a winter abroad may feel premature. but much like the colder days, deadlines often arrive sooner than we’d like them to.

one such deadline is one for mitacs’s globalink research award (gra). 世界杯2022赛程表淘汰赛 wishing to travel in january 2019 with $6,000 in gra support should submit their applications by september 30, 2018. 世界杯2022赛程表淘汰赛 can submit applications at any time, but are encouraged to apply at least 16 weeks prior to their planned departure.

destinations now include australia, china, eu member countries, japan, and the united states — the complete list of eligible destinations is on the award web page, along with a searchable “find a professor” list of professors interested in hosting 世界杯2022赛程表淘汰赛 from canada.

if you have any questions, contact international@mitacs.ca. we look forward to receiving your applications.

the fy18 defense appropriation provides $12 million (m) to the department of defense reconstructive transplant research program (rtrp) to support research projects that specifically address needs in the field of vascularized composite allotransplantation (vca).  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

fy18 rtrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

focus areas:  the fy18 rtrp encourages research projects that specifically address needs in the field of vascularized composite allotransplantation (vca) in the following focus areas:

·         reduce the risks of vca-associated immunotherapy

·         revolutionize ex vivo vca tissue preservation strategies to extend the timeline between procurement and transplantation

·         identify near- and long-term functional, quality-of-life, and psychosocial outcomes in vca

investigator-initiated research award (iira) – preproposal due 8/15/18

independent investigators at all academic levels (or equivalent)

·         preproposal is required; full application submission is by invitation only.

·         supports studies with potential to make an important contribution to the reconstructive transplant research field, patient care, and/or quality of life.

·         preliminary or published data required.

·         multiple pi option supports synergistic partnerships among two to four investigators collaborating on a single application; multi-institutional collaborations are encouraged.

·         applications must address at least one of the fy18 rtrp focus areas.

individual pis:

·       maximum funding of $1 million (m) for total costs

·       maximum period of performance is 3 years

multiple pi option:

·       maximum funding of $1.5m for total costs

·       maximum period of performance is 3 years

qualitative research award (qra) – preproposal due 8/15/18

independent investigators at all academic levels (or equivalent)

·         preproposal is required; full application submission is by invitation only.

·         supports qualitative research studies that will help researchers and clinicians to better understand the experiences of individuals who are considering, or have already received, reconstructive transplant surgery.

·         demonstrated qualitative research experience within the research team is required.

·         applications must address the following fy18 rtrp focus area:

○        identify near- and long-term functional, quality-of-life, and psychosocial outcomes in vca

multiple pi option supports synergistic partnerships among two to four investigators collaborating on a single application; multi-institutional collaborations are encouraged.

·       maximum funding of $1m for total costs

·       maximum period of performance is 3 years

multiple pi option:

·       maximum funding of $1.5m for total costs

·       maximum period of performance is 3 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the rtrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507
help@ebrap.org

the fy18 defense appropriation provides $12 million (m) to the department of defense reconstructive transplant research program (rtrp) to support research projects that specifically address needs in the field of vascularized composite allotransplantation (vca).  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

fy18 rtrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

focus areas:  the fy18 rtrp encourages research projects that specifically address needs in the field of vascularized composite allotransplantation (vca) in the following focus areas:

·         reduce the risks of vca-associated immunotherapy

·         revolutionize ex vivo vca tissue preservation strategies to extend the timeline between procurement and transplantation

·         identify near- and long-term functional, quality-of-life, and psychosocial outcomes in vca

http://cdmrp.army.mil/funding/rtrp

concept award (ca) – letter of intent due 10/3/18

investigators at or above the level of postdoctoral fellow (or equivalent)

·         pre-application (letter of intent) is required.

·         supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to reconstructive transplant. 

·         preliminary data are not allowed.

·         reviewers at both tiers of review will be blinded to the identity of the principal investigator (pi), collaborators, and their organizations.

·         applications must address at least one of the fy18 rtrp focus areas.

·       maximum funding of $200,000 for total costs (direct plus indirect costs)

·       maximum period of performance is 18 months